Skip to main content
OpenTrials

Clinical trial condition

Metastatic Breast Cancer

Explore clinical trials studying Metastatic Breast Cancer. Study availability and eligibility vary by location and protocol.

640 public trials 137 recruiting studies
Refine in advanced search Browse all conditions

Metastatic Breast Cancer trial results

Recruiting

Improving Survival for Metastatic Lobular Breast Cancer (PLUMB Registry)

NCT05964504

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +11 more
Locations
  • University of California, San Diego San Diego, California, United States
  • University of California, San Francisco San Francisco, California, United States
  • Abramson Cancer Center Philadelphia, Pennsylvania, United States
  • MD Anderson Cancer Center Houston, Texas, United States
View Trial Details
Recruiting

The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study

NCT06377852

Conditions
Breast Diseases, Breast Neoplasms, Metastatic Breast Cancer, +4 more
Locations
  • Ironwood Cancer & Research Centers Chandler, Arizona, United States
  • Ironwood Cancer & Research Centers Gilbert, Arizona, United States
  • Ironwood Cancer & Research Centers Glendale, Arizona, United States
  • Ironwood Cancer & Research Centers Goodyear, Arizona, United States
View all 73 locations
View Trial Details
Recruiting

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

NCT06625775

Conditions
Advanced Breast Cancer, Advanced Lung Cancer, Breast Diseases, +35 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • University of California Los Angeles Los Angeles, California, United States
  • University of California San Diego Moores Cancer Center San Diego, California, United States
  • UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
View all 40 locations
View Trial Details
Recruiting

BGB-21447 (Bcl-2 Inhibitor) Combinations for Adults With Hormone-Receptor Positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Metastatic Breast Cancer

NCT06756932

Conditions
Breast Diseases, Breast Neoplasms, HER2-negative Breast Cancer, +6 more
Locations
  • University of Iowa Hospitals and Clinics Iowa City, Iowa, United States
  • Md Anderson Cancer Center Houston, Texas, United States
  • Fred Hutchinson Cancer Research Center Seattle, Washington, United States
  • Saint Vincents Hospital Sydney Darlinghurst, New South Wales, Australia
View all 14 locations
View Trial Details
Recruiting

Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation

NCT05696626

Conditions
Breast Diseases, Breast Neoplasms, Metastatic Breast Cancer, +4 more
Locations
  • Mayo Clinic - Scottsdale Scottsdale, Arizona, United States
  • University of Arizona - Cancer Center Tucson, Arizona, United States
  • Providence Medical Foundation - Santa Rosa, CA Santa Rosa, California, United States
  • Mayo Clinic - Jacksonville Jacksonville, Florida, United States
View all 224 locations
View Trial Details
Recruiting

Phase 1/2 Study to Evaluate EP0062 as Monotherapy and in Combination in Patients With Advanced or Metastatic AR+/HER-2-/ER+ Breast Cancer

NCT05573126

Conditions
Breast Diseases, Breast Neoplasms, Hormone Receptor Positive HER-2 Negative Breast Cancer, +6 more
Locations
  • Yale School of Medicine New Haven, Connecticut, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Henry Ford Hospital Detroit, Michigan, United States
View all 14 locations
View Trial Details
Recruiting

Scalp Cooling in MBC

NCT04986579

Conditions
Breast Diseases, Breast Neoplasms, Chemotherapy-induced Alopecia, +5 more
Locations
  • Brigham and Women's Hospital Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Recruiting

CD40 Agonist, Flt3 Ligand, and Chemotherapy in HER2 Negative Breast Cancer

NCT05029999

Conditions
Breast Diseases, Breast Neoplasms, HER2-negative Breast Cancer, +5 more
Locations
  • University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
  • Johns Hopkins University Baltimore, Maryland, United States
  • University of North Carolina Chapel Hill, North Carolina, United States
  • Sarah Cannon Research Institute Nashville, Tennessee, United States
View Trial Details

Related conditions